Just days after announcing sweeping job cuts at NHS England, UK Prime Minister Keir Starmer has said that the government intends to do away with the centre altogether.

Mallinckrodt and Endo were both involved in the sale of opioid painkillers and faced litigation claiming that they played a ...

Certain companies seem particularly relentless. Their ads don’t explicitly name the drugs they prescribe, but they don’t need to. Suggestive phrases like “doctor-supported weight loss” and “clinically ...

Sichuan Kelun-Biotech Biopharma has become the first drugmaker to usher a TROP2-targeted antibody-drug conjugate to ...

One of the key open questions in cell and gene therapy is which will win out: autologous cell therapies, where the patient’s own blood is modified at the bedside, or allogeneic therapies, created with ...

Roche has parted with $1.4 billion upfront to secure rights to an obesity candidate developed by Zealand Pharma, taking its ...

Manually producing the TLF involves an interplay of biostatisticians, terminology coders, statistical programmers, and ...

Backed by funding from the Gates Foundation, software company Psyon is running a pilot study of a game that aims to raise ...

The European Commission has proposed new legislation to safeguard the supply of critical medicines in the EU by boosting manufacturing within the bloc and reducing dependency on suppliers from other ...

The list price of Mavenclad is around £2,050 per 10mg tablet, although, Merck is providing it to the NHS in England at a ...

MSD has opened the doors of a $1 billion manufacturing facility at its site in Durham, North Carolina, that will be used to ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...